Litcius/Paper detail

Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway

Ya‐Jia Xie, Weina Gao, Qibiao Wu, Xiaojun Yao, Zebo Jiang, Yuwei Wang, Wenjun Wang, Wěi Li, Shahid Hussain, Liang Liu, Elaine Lai‐Han Leung, Xing‐Xing Fan

2020Pharmacological Research44 citationsDOI

Topics & Concepts

GefitinibT790MAfatinibAMPKCancer researchApoptosisTyrosine kinaseBiologyMitochondrial respiratory chainKinasePharmacologyChemistryMitochondrionEpidermal growth factor receptorSignal transductionCell biologyProtein kinase ABiochemistryReceptorQuinazolinone synthesis and applicationsCancer therapeutics and mechanismsBerberine and alkaloids research
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway | Litcius